|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.369 EUR | +9.81% |
|
+14.50% | -14.29% |
| 06-15 | Clinuvel Pharmaceuticals Advances US Listing Plan With SEC Filing for Nasdaq ADS Upgrade | MT |
| 04-27 | Clinuvel Pharmaceuticals plans level II ADR upgrade and Nasdaq listing as CUVL | RE |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CUV Stock
- UR9 Stock
- Charts Clinuvel Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
